NEOPLAMS
Clinical trials for NEOPLAMS explained in plain language.
Never miss a new study
Get alerted when new NEOPLAMS trials appear
Sign up with your email to follow new studies for NEOPLAMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Antibody-Drug conjugate enters early human trials for advanced cancers
Disease control Not yet recruitingThis Phase 1 trial tests MST-168, an antibody-drug conjugate designed to target and kill cancer cells. It will enroll 420 adults with advanced solid tumors that have specific markers. The main goals are to check safety, find the right dose, and see early signs of tumor shrinkage.
Matched conditions: NEOPLAMS
Phase: PHASE1 • Sponsor: Mabsoft Therapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New cancer drug SIG001 enters first human tests
Disease control Not yet recruitingThis early-stage trial tests a new biologic drug, SIG001, in 66 people with advanced solid tumors. The main goals are to check safety, find the right dose, and see how the drug behaves in the body. Participants receive SIG001 intravenously every two weeks and are monitored for si…
Matched conditions: NEOPLAMS
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Jumping into recovery: plyometric exercise may boost breast cancer Survivors' Well-Being
Symptom relief Not yet recruitingThis study compares a plyometric strength-endurance exercise program to conventional strength training in 51 women who are breast cancer survivors or currently undergoing treatment. Over 12 weeks, participants will attend supervised 60-minute sessions twice a week. Researchers wi…
Matched conditions: NEOPLAMS
Phase: NA • Sponsor: University of Vigo • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC